PMID: 8611418Apr 1, 1996Paper

Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group

British Journal of Cancer
Peter SasieniE Lynch-Farmery

Abstract

The screening histories of all 348 women with invasive cervical cancer diagnosed in 1992 in 24 self-selected district health authorities and health boards in England, Wales and Scotland were compared with those of 677 age- and residency-matched controls. The controls were randomly selected from the family health services authority (FHSA) register. Screening histories, comprising the dates and results of all smears taken before the date of diagnosis of the patient's cancer, were determined from the FHSA computer and laboratory records. We estimate that the number of cases of cervical cancer in participating districts in 1992 would have been 57% (95% confidence interval 28-86%) greater if there had been no previous screening. In women under the age of 70 it would have been approximately 75% (31-115%) greater. Extrapolation of the results from this pilot suggests that screening prevented between 1100 and 3900 cases of invasive cervical cancer in the UK in 1992. Women with stage 1B cancer or worse were more likely to have no record of previous screening than controls: 47% of these women under the age of 70 had been adequately screened according to current (5 yearly screening) guidelines, compared with 75% of matched controls. Thirt...Continue Reading

Citations

Aug 1, 1997·British Journal of Obstetrics and Gynaecology·J Patnick
Feb 1, 1997·Genitourinary Medicine·M Fitzgerald
Feb 18, 1998·International Journal of Cancer. Journal International Du Cancer·A P VizcainoD M Parkin
Jan 30, 1999·Sexually Transmitted Infections·J Cuzick
Jun 22, 2001·Pharmacoepidemiology and Drug Safety·J Cuzick
Sep 20, 2005·Acta Obstetricia Et Gynecologica Scandinavica·Anna de LangErik Wilander
Jul 14, 2005·British Journal of Cancer·G RoncoUNKNOWN Turin Cervical Screening Working Group
Jan 18, 2006·Epidemiology and Infection·C M Lowndes
Oct 20, 2006·Journal of Lower Genital Tract Disease·Debbie SaslowCarmel Cohen
Dec 15, 2006·BJOG : an International Journal of Obstetrics and Gynaecology·P PriestR Jackson
Oct 11, 2008·International Journal of Cancer. Journal International Du Cancer·Peter SasieniD Max Parkin
Dec 2, 2008·Cytopathology : Official Journal of the British Society for Clinical Cytology·Roberto Dina
May 19, 2009·International Journal of Cancer. Journal International Du Cancer·Peter SasieniJack Cuzick
Jul 22, 2014·Obstetrics and Gynecology International·Christopher M Tarney, Jasmine Han
Jun 14, 2014·International Journal of Cancer. Journal International Du Cancer·Remko P BosgraafRuud L M Bekkers
Aug 27, 2015·PloS One·Sarika JalanAlok Yadav
Apr 22, 1999·Cytopathology : Official Journal of the British Society for Clinical Cytology·J D WilsonJ Sutton
Apr 6, 2001·International Journal of Cancer. Journal International Du Cancer·R KlaesM von Knebel Doeberitz
Aug 17, 1999·International Journal of Cancer. Journal International Du Cancer·A AnttilaM Hakama
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Pekka NieminenAhti Anttila
Apr 6, 2006·International Journal of Cancer. Journal International Du Cancer·Jack CuzickThomas Iftner
Apr 3, 2003·British Journal of Cancer·M E van den Akker-van MarleJ D F Habbema
Jul 25, 2008·BJOG : an International Journal of Obstetrics and Gynaecology·D A M HeidemanC J L M Meijer
Nov 19, 2009·International Journal of Cancer. Journal International Du Cancer·Lara TerminiLuisa Lina Villa
Nov 21, 2009·Diagnostic Cytopathology·Jasleen KaurNalini Gupta
Mar 1, 2011·Journal of Women's Health·Sarah IgidbashianMario Sideri
Sep 8, 2011·British Journal of Cancer·R S KellyUNKNOWN NHSCSP HPV Special Interest Group
Mar 1, 2012·Cancer Cytopathology·Rebecca AlbrowMina Desai
Dec 29, 2010·Archives of Gynecology and Obstetrics·Nahid KhodakaramiKamyab Alizadeh
May 4, 2011·Reviews in Medical Virology·Channa E SchmeinkWillem J G Melchers
Apr 3, 2014·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Beti ThompsonCatherine Duggan
Aug 16, 2015·American Journal of Clinical Pathology·Jennifer L ReidCristina Giachetti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.